Sorrento Therapeutics ^Investors

Sorrento Therapeutics is a private equity firm headquartered in San Diego, California, established in 2006 The firm specializes in the development and commercialization of innovative biopharmaceutical products Sorrento Therapeutics focuses on advancing therapies in oncology, immunology, and pain management, leveraging its proprietary technologies The firm has engaged in significant investments, with a notable scale of approximately $30,000,000, to support its strategic initiatives and research endeavors Sorrento Therapeutics is committed to addressing unmet medical needs through its robust pipeline and collaborative partnerships